Medtronic plc

Equities

MDT

IE00BTN1Y115

Medical Equipment, Supplies & Distribution

Market Closed - Nyse Other stock markets 04:00:02 2025-07-11 pm EDT			5-day change	1st Jan Change
89.92 ^USD	+0.58%		+1.73%	+12.57%

Jul. 11	Medtronic Says Centers for Medicare & Medicaid Services Proposes National Coverage for Blood Pressure Treatment Device	MT
Jul. 10	Jabil Inc. : Investing to stay ahead

Foundry Innovation & Research 1, Ltd. announced that it has received $120 million in funding from a group of investors

Published on 01/06/2025 at 18:00

Foundry Innovation & Research 1, Ltd. announced that it has received $120 million in a round of funding co-led by new investors Elevage Medical Technologies and Polaris Partners L.P. on January 7, 2025. The transaction included participation from new investors Sands Capital Management, LLC, Ireland Strategic Investment Fund, Longitude Capital Management Co., LLC, returning investors Gilde Healthcare Partners B.V., Andera Partners, Gimv NV, Medtronic plc, New Enterprise Associates, Inc., Novo Holdings A/S and Seventure Partners. Elevage Medical Technologies, Polaris Partners L.P.Ireland Strategic Investment Fund has invested $22 million.

Ellie McGuire, Partner from Polaris Partners L.P., and Michael Wasserman Elevage Medical Technologies will join board of directors. The company has received $213 million in funding till date

Stocks mentioned in the article

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Price	Change	5d. change	Capi.
	MEDTRONIC PLC	89.92USD	+0.58%	+1.73%	115B
	GIMV NV	41.60EUR	0.00%	+1.09%	1.74B

Latest news about Medtronic plc

Medtronic Says Centers for Medicare & Medicaid Services Proposes National Coverage for Blood Pressure Treatment Device	Jul. 11	MT
Jabil Inc. : Investing to stay ahead	Jul. 10
Evercore ISI Adjusts Price Target on Medtronic to $106 From $103, Maintains Outperform Rating	Jul. 08	MT
Medtronic Appoints Chad Spooner as Chief Financial Officer of MiniMed, Effective July 14, 2025	Jul. 08	CI
Medtronic Appoints Chad Spooner as CFO of Planned Diabetes Firm	Jul. 08	MT
Philips: expands partnership with US company Medtronic	Jul. 02	CF
Medtronic Shares Rise After Upgrade From Wolfe Research	Jun. 30	MT
Wolfe Research Upgrades Medtronic to Peer Perform From Underperform	Jun. 30	MT
Medtronic plc Appoints Dr. Joon Lee as A New Director and Member of Science and Technology Committee and the Compensation and Talent Committee, Effective as of June 18, 2025	Jun. 23	CI
Tranche Update on Medtronic plc's Equity Buyback Plan announced on June 23, 2017.	Jun. 20	CI
Jefferies Adjusts Price Target on Medtronic to $94 From $90	Jun. 20	MT
Texas Instruments Plans to Invest More Than $60 Billion to Manufacture Billions of Bel foundational Semiconductors in the U.S	Jun. 18	CI
Opyl Limited Appoints Matt Hallam as Chief Revenue Officer, Effective June 17, 2025	Jun. 16	CI
Leerink Partners Initiates Medtronic at Outperform With $110 Price Target	Jun. 16	MT
Medtronic's New Diabetes Company to Be Named MiniMed	Jun. 12	MT
Medtronic Announces MiniMed As Name For Planned New Diabetes Company	Jun. 12	RE
Medtronic Announces MiniMed As Name For Planned New Diabetes Company	Jun. 12	RE
Some of the biggest splits in Corporate America	Jun. 09	RE
Some of the biggest splits in Corporate America	Jun. 09	RE
Medtronic's Separation of Diabetes Business May Drive Long-Term Value, Needham Says	Jun. 06	MT
FDA Says Medtronic Had Removed Shiley Adult Flexible Tracheostomy Tube	Jun. 05	RE
DBS Bank Adjusts Price Target on Medtronic to $82 From $90, Maintains Hold Rating	Jun. 02	MT
Goldman Sachs Adjusts Price Target on Medtronic to $78 From $85, Maintains Sell Rating	Jun. 02	MT
HealthCare Global Enterprises Limited Announces Chief Executive Officer Changes, Effective 30 June 2025	May. 30	CI
Medtronic plc Presents at Bernstein 41st Annual Strategic Decisions Conference 2025, May-29-2025 11:00 AM	May. 29

Chart Medtronic plc

Duration

Period

MDT: Dynamic Chart

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (26%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.5%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (18%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - cranial and spinal technologies (14.7%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (9%); - diabetes management (7.7%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.4%): neurostimulation and pumped medication administration products, diagnostic tools, etc. ; - other (0.7%). Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).

Employees

95,000

Sector

Medical Equipment, Supplies & Distribution

Calendar

Aug. 19 - Q1 2026 Earnings Release

More about the company